PFBT
ORGO icon

Parkside Financial Bank & Trust’s Organogenesis Holdings ORGO Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-111
Closed -$299 – 2079
2022
Q4 		$299 Buy
+111
New +$324 ﹤0.01% 1945
2022
Q2 		– Sell
-169
Closed -$1K – 1910
2022
Q1 		$1K Sell
169
-138
-45% -$1.07K ﹤0.01% 1746
2021
Q4 		$3K Buy
307
+202
+192% +$2.15K ﹤0.01% 1516
2021
Q3 		$1K Buy
+105
New +$1.63K ﹤0.01% 1690

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Parkside Financial Bank & Trust's ORGO Position: Q1 2023 in Review

Parkside Financial Bank & Trust sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 111 shares — an estimated $299 sold.

Parkside Financial Bank & Trust first reported a position in ORGO in Q3 2021 and held it in 4 quarters. The position peaked at $3K in Q4 2021. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

  • Parkside Financial Bank & Trust reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 111 Organogenesis Holdings shares in Q1 2023, an estimated $299.
  • Parkside Financial Bank & Trust first reported a position in Organogenesis Holdings in Q3 2021 and held it in 4 quarters.
  • Parkside Financial Bank & Trust's Organogenesis Holdings position peaked at $3K in Q4 2021.
  • 131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2023, filed 4 May 2023.